User login
Higher levels of LDL cholesterol, HDL cholesterol, and triglycerides over a lifetime are protective against type 2 diabetes, a Mendelian randomization study has shown. Jon White, PhD, of University College London and his co-investigators sought to shed light on the role of the most commonly measured lipid fractions—LDL cholesterol, HDL cholesterol, and triglycerides—in the development of coronary artery disease and diabetes, particularly the observed link between statin therapy and an increased risk of diabetes. More on the study, and how the results can help to identify the potential effects of lipid-modifying drugs, is available at Family Practice News: http://www.familypracticenews.com/specialty-focus/cardiology/single-article-page/rises-in-ldl-and-hdl-cholesterol-triglycerides-tied-to-lower-diabetes-risk/1c99fd4b400f60185df3f4de7d895f5f.html.
Higher levels of LDL cholesterol, HDL cholesterol, and triglycerides over a lifetime are protective against type 2 diabetes, a Mendelian randomization study has shown. Jon White, PhD, of University College London and his co-investigators sought to shed light on the role of the most commonly measured lipid fractions—LDL cholesterol, HDL cholesterol, and triglycerides—in the development of coronary artery disease and diabetes, particularly the observed link between statin therapy and an increased risk of diabetes. More on the study, and how the results can help to identify the potential effects of lipid-modifying drugs, is available at Family Practice News: http://www.familypracticenews.com/specialty-focus/cardiology/single-article-page/rises-in-ldl-and-hdl-cholesterol-triglycerides-tied-to-lower-diabetes-risk/1c99fd4b400f60185df3f4de7d895f5f.html.
Higher levels of LDL cholesterol, HDL cholesterol, and triglycerides over a lifetime are protective against type 2 diabetes, a Mendelian randomization study has shown. Jon White, PhD, of University College London and his co-investigators sought to shed light on the role of the most commonly measured lipid fractions—LDL cholesterol, HDL cholesterol, and triglycerides—in the development of coronary artery disease and diabetes, particularly the observed link between statin therapy and an increased risk of diabetes. More on the study, and how the results can help to identify the potential effects of lipid-modifying drugs, is available at Family Practice News: http://www.familypracticenews.com/specialty-focus/cardiology/single-article-page/rises-in-ldl-and-hdl-cholesterol-triglycerides-tied-to-lower-diabetes-risk/1c99fd4b400f60185df3f4de7d895f5f.html.